
Enlivex Therapeutics Ltd. ENLV
€ 0.97
0.0%
Geschäftsbericht 2024
hinzugefügt 21.02.2026
Enlivex Therapeutics Ltd. EV 2011-2026 | ENLV
EV Jährlich Enlivex Therapeutics Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 122 M | 122 M | 74.9 M | 22.7 M | 59.1 M | 9.74 M | 54.4 M | 91.6 M | -139 K | -65 K | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 122 M | -139 K | 55.6 M |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.82 B | - | 2.43 % | $ 254 M | ||
|
Graybug Vision
GRAY
|
8.71 M | - | -11.23 % | $ 9.65 M | ||
|
Apellis Pharmaceuticals
APLS
|
3.01 B | $ 19.87 | -1.44 % | $ 2.51 B | ||
|
Aptorum Group Limited
APM
|
9.45 M | $ 0.82 | 3.61 % | $ 4.47 M | ||
|
I-Mab
IMAB
|
8.28 B | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
1.95 B | - | - | $ 40.3 B | ||
|
Acer Therapeutics
ACER
|
38.2 M | - | 2.71 % | $ 14 M | ||
|
Biophytis SA
BPTS
|
525 M | - | -13.47 % | $ 169 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-1.05 M | - | -11.43 % | $ 502 K | ||
|
AbCellera Biologics
ABCL
|
1.22 B | $ 3.66 | -1.43 % | $ 1.09 B | ||
|
Athersys
ATHX
|
-37.4 M | - | 3.77 % | $ 22.4 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
3.41 B | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
4.79 M | - | -18.52 % | $ 27.3 M | ||
|
AVEO Pharmaceuticals
AVEO
|
86.9 M | - | - | $ 521 M | ||
|
Axsome Therapeutics
AXSM
|
8.95 B | $ 163.94 | -0.07 % | $ 8.16 B | ||
|
Brainstorm Cell Therapeutics
BCLI
|
15.7 M | - | -2.5 % | $ 5.88 M | ||
|
BioDelivery Sciences International
BDSI
|
445 M | - | -4.8 % | $ 255 M | ||
|
Burford Capital Limited
BUR
|
3.22 B | $ 8.43 | -1.4 % | $ 1.39 B | ||
|
BridgeBio Pharma
BBIO
|
15.5 B | $ 65.12 | 0.91 % | $ 12.5 B | ||
|
Adverum Biotechnologies
ADVM
|
125 M | - | - | $ 86.2 M | ||
|
CymaBay Therapeutics
CBAY
|
3.36 B | - | - | $ 3.45 B | ||
|
Институт стволовых клеток человека
ISKJ
|
14.1 M | - | - | - | ||
|
Avid Bioservices
CDMO
|
661 M | - | - | $ 789 M | ||
|
ARCA biopharma
ABIO
|
436 M | - | 1052.0 % | $ 415 M | ||
|
BioMarin Pharmaceutical
BMRN
|
11.9 B | $ 59.06 | 0.91 % | $ 11.3 B | ||
|
Checkpoint Therapeutics
CKPT
|
174 M | - | - | $ 169 M | ||
|
Caladrius Biosciences
CLBS
|
-6.94 M | - | -16.75 % | $ 25.8 M | ||
|
Alpine Immune Sciences
ALPN
|
363 M | - | - | $ 2.17 B | ||
|
Clovis Oncology
CLVS
|
839 M | - | -7.23 % | $ 13 M | ||
|
Acorda Therapeutics
ACOR
|
-13.2 M | - | -24.86 % | $ 820 K | ||
|
Checkmate Pharmaceuticals
CMPI
|
11.4 M | - | - | $ 231 M | ||
|
Acasti Pharma
ACST
|
24 M | - | 4.01 % | $ 150 M | ||
|
CTI BioPharma Corp.
CTIC
|
664 M | - | - | $ 1.2 B | ||
|
CohBar
CWBR
|
410 K | - | -15.44 % | $ 2.2 M | ||
|
Cyclacel Pharmaceuticals
CYCC
|
8.71 M | - | -5.98 % | $ 34.1 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
112 M | - | -4.36 % | $ 27 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
1.24 B | - | - | $ 2.18 B | ||
|
Cabaletta Bio
CABA
|
-155 M | $ 3.25 | 0.03 % | $ 3.8 M | ||
|
Capricor Therapeutics
CAPR
|
177 M | $ 25.35 | -1.92 % | $ 679 M | ||
|
CureVac N.V.
CVAC
|
3.19 B | - | - | $ 867 M | ||
|
Aeterna Zentaris
AEZS
|
5.52 M | - | 5.93 % | $ 314 M | ||
|
Codexis
CDXS
|
354 M | $ 0.97 | -1.14 % | $ 71.2 M | ||
|
Corvus Pharmaceuticals
CRVS
|
88.4 M | $ 17.25 | -1.6 % | $ 828 M | ||
|
AgeX Therapeutics
AGE
|
6.28 M | - | -10.17 % | $ 12.2 K | ||
|
Certara
CERT
|
1.38 B | $ 7.44 | 2.69 % | $ 1.19 B | ||
|
Aeglea BioTherapeutics
AGLE
|
-23.2 M | - | - | $ 1.01 B | ||
|
Coherus BioSciences
CHRS
|
929 M | $ 1.71 | 3.33 % | $ 161 M | ||
|
Entasis Therapeutics Holdings
ETTX
|
51.1 M | - | - | $ 105 M | ||
|
Evofem Biosciences
EVFM
|
75.8 M | - | 7.55 % | $ 38.1 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-9.16 M | - | - | $ 26.5 M |